Markets:

Overview

News

Currencies

International

Treasuries

State Street SPDR S&P Biotech ETF (NY:XBI)

124.25 +2.42 (+1.99%)

Streaming Delayed Price Updated: 10:59 AM EDT, Mar 16, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about State Street SPDR S&P Biotech ETF

< Previous 1 2

...

9 10 11 12 13 14 15 16 Next >

Sector Shift Stalls Healthcare Stocks But Biotech Shows Gains In January ↗

January 30, 2023

Biotech stocks are off to a great start in 2023 with the IBB up 4.5% and the XBI up 7.7%.

Via Talk Markets

2 ETFs That Can Set You Up for Life ↗

January 25, 2023

Simplifying your investment strategy can help minimize your risk while still allowing you to earn some great returns.

Via The Motley Fool

Healthcare Sector Is Lagging As We Enter 2022 Earnings Season ↗

January 23, 2023

The healthcare sector is perceived as defensive but in 2023 there is more investor appetite for risk based on the QQQ comeback and the XBI strength.

Via Talk Markets

The Fed Should Stop Right Now ↗

January 19, 2023

A pause to refresh or a mild pullback would be good for the stock market after running hot and heavy. On Wednesday, we saw weaker economic data in retail sales. Unlike previous soft data, the stock...

Via Talk Markets

J.P.Morgan Healthcare Conference JPM23: Biotech Rally Favors Smaller Caps ↗

January 17, 2023

Large cap biopharmas that outperformed in 2022 were generally weak last week from profit-taking and portfolio rebalancing.

Via Talk Markets

Choppy Days Lie Ahead So Why Fight The Fed? ↗

October 10, 2022

We are in a bear market with choppy days over the next few months.

Via Talk Markets

Nice Gains During JPM23 Week: Benign CPI Report Brings Hope For A “Soft Landing” ↗

January 12, 2023

Small-cap speculative biotech stocks regain interest with volatility.

Via Talk Markets

3 Unstoppable ETFs to Stock Up On in 2023 ↗

January 09, 2023

These ETFs could be big winners in the new year.

Via The Motley Fool

ETFs To Buy For 2023 After S&P 500's Worst Year Since 2008 ↗

January 08, 2023

The S&P 500 has dropped 19.4% in 2022. It marked the largest calendar-year decline since a 38% plunge in Lehman Bother’s crisis-laden 2008. Goldman Sachs, Bank of America and JPMorgan predict a U.S....

Via Talk Markets

CRISPR, Genetics And AI — Why 2023 Could Be The Year For Biotech Stocks ↗

January 06, 2023

Genetic medicine is a top theme now for biotech stocks. Other trends are heating up too.

Via Investor's Business Daily

5 Top Stocks for January ↗

January 01, 2023

Now is the time to begin crafting your watch list for 2023.

Via The Motley Fool

The Year In Review And Ahead ↗

December 29, 2022

We‘ll continue witnessing cost-push inflation combined with tight labor market – and it would be crude oil‘s time again to gain in value from current levels.

Via Talk Markets

Biogen's 2nd Alzheimer's Antibody, BeiGene's Cancer Drug Label Expansion, Adcom Test For Regeneron And More: January PDUFA Catalysts For Biotech Investors ↗

December 27, 2022

Biopharma stocks were not immune to the broader market downturn seen for much of 2022.

Via Benzinga

2 Top Biotech Stocks to Buy for the Long Haul ↗

December 25, 2022

These mid-cap biotechs are solid long-term choices.

Via The Motley Fool

Tuesday Talk: Where is Santa? ↗

December 20, 2022

Monday continued the downtrend for the major indices on Wall Street which concluded a second week of losses on Friday. As for an annual Santa rally, that seems nowhere to be found.

Via Talk Markets

Healthcare Portfolio Is Doing Well But Biotech Stocks Are Mired In Macro ↗

December 19, 2022

The biotech sector has not done well in 2022 despite some strong runs. Small and mid-cap stocks are more “risk-off’ with interest rates rising and sentiment waning.

Via Talk Markets

The 7 Hottest Biotech Stocks to Own in 2023 and Beyond ↗

December 18, 2022

Biotech is one of the safest, recession-proof sectors on the market. It's why we're going after the hottest biotech stocks in the New Year.

Via InvestorPlace

Mirati Plays Catch-Up With Amgen, Gilead's 2nd Try With AIDS Drug, Cytokinetics' Adcom Test And More: Key Nov FDA Decisions For Biotech Investors ↗

December 02, 2022

Food and Drug Administration decisions and advisory committee verdicts slated for November were mostly positive. New molecular entity approvals so far this year trail 2021’s tally by about 35%.

Via Benzinga

Uncertainty Grips Markets-On A Clear Day Maybe You Can See A Week Ahead ↗

November 28, 2022

Healthcare stocks are now favored by many strategists because of their defensive nature and focus on US markets.

Via Talk Markets

The 10 Most Shorted ETFs: Which Sectors Saw Short Interest Increase? ↗

November 22, 2022

Investors often short stocks to hedge positions against long positions or as a way to bet against a particular company. Benzinga provides a look at the most shorted stocks here.

Via Benzinga

My 3 Top Biotech Stock Picks for 2023 ↗

November 22, 2022

Biotech stocks are set to shine in 2023.

Via The Motley Fool

Stocks Drop On November 17 As The Dollar Moves Higher ↗

November 17, 2022

Stocks dropped as the dollar pushed higher ahead of options expiration.

Via Talk Markets

Why Emergent Bio Is Leading A Biotech Bloodbath — With Xenon Pharma Trailing ↗

November 09, 2022

Biotech stocks were hammered Wednesday, including several that had good news.

Via Investor's Business Daily

2 Healthcare Stocks Poised to Rocket Higher in the 4th Quarter ↗

November 06, 2022

These two healthcare stocks could deliver market-crushing gains by year's end.

Via The Motley Fool

What To Watch In The S&P Biotech ETF After Johnson & Johnson's $16.6B Abiomed Deal ↗

November 01, 2022

As the exodus out of mega-cap technology stocks continues, investors and money managers are looking for other sectors to rotate into.

Via Benzinga

Can Biotech Stocks Continue Rallying In This Bear Market? ↗

October 31, 2022

Via Talk Markets

This Beaten-Down ETF Is Still a Screaming Bear-Market Buy ↗

October 21, 2022

Investors wanting to profit from a potential biotech sector bounce should love this exchange-traded fund.

Via The Motley Fool

Steady As She Goes With Healthcare Stocks ↗

October 17, 2022

Favorable seasonality lies ahead for Q4 with a caveat of Q3 earnings reports.

Via Talk Markets

My 3 Biggest Stock Market Predictions for October ↗

October 11, 2022

Now's not the best time to bet the farm on anything other than more uncertainty coming up.

Via The Motley Fool

Stocks May Be Nearing A Breaking Point ↗

September 27, 2022

We are seeing high yield spreads widen, and looking at the ratio of the SHY to HYG; it is clear that we surpassed the June highs.

Via Talk Markets

< Previous 1 2

...

9 10 11 12 13 14 15 16 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.